Hello! Not to spoil the shock but the news is that I'm leaving STAT after eight wonderful years and will soon be covering some very large drug companies with the team Bloomberg News.

Medicare expects to spend $3.5 billion on the Alzheimer's treatment Leqembi in 2025 — well beyond what Wall Street or even the drug's manufacturer has projected. Read more from Rachel Cohrs Zhang and me: statnews.com/2024/04/11/med…

More tumult at BIO: The group's top lobbyist exits suddenly, and its new CEO signals that more changes may be on the way statnews.com/2024/04/10/bio…

We need to talk about Buddy.

Amid our own mental health crisis, more and more pets are on Prozac and other SSRIs. What that says about our understanding of behavioral health and our resources:
statnews.com/2024/04/05/dog…

Why the world’s most expensive drug might not be all that overpriced

In which I shill for the makers of some multi million dollar medicines

statnews.com/2024/03/28/gen…

Does decaf coffee contain a harmful additive? Advocates want to ban a certain chemical in the brew statnews.com/2024/03/28/dec…

Supreme Court mifepristone arguments focus on physicians' right to sue, not FDA judgment statnews.com/2024/03/26/sup…

Nvidia says generative AI will revolutionize health care. So did IBM, with Dr. Watson statnews.com/2024/03/25/nvi…

When my editors asked me to chart out who won and lost in the Covid vaccine race, I thought, 'old news.'

But get this: the worse a large pharma did at Covid vaccines, the better they are doing now.

That's not great if there is another pandemic.

statnews.com/2024/03/25/cov…

Gene-edited pig kidney transplanted into a living patient for the first time statnews.com/2024/03/21/fir…

Very excited to announce STAT's first Disability in Healthcare Reporting Fellow, Timmy Broderick!

Timmy has a sharp vision of what compelling disability coverage looks like, and I can't wait to see what they do as a fellow. statnews.com/stat-hires-dis…

The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform statnews.com/2024/03/19/met…

Intermittent fasting comes with a heart risk? Not so fast statnews.com/2024/03/19/int…

We are now accepting applications for the Sharon Begley Science Reporting Fellowship. It combines a paid reporting position at STAT with an educational component through the prestigious KSJ at MIT Knight Science Journalism program at Massachusetts Institute of Technology (MIT)

statnews.com/careers/sharon…

Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?

statnews.com/2024/03/13/hem…

A STAT update that I am excited to share with all of you:

I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusive — and FREE — for current STAT subscribers.

One catch: I need you to sign up, which you can do here…

Rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction statnews.com/2024/03/12/met…

Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next statnews.com/2024/03/08/amy… $amlx

Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label statnews.com/2024/03/08/obe…

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug statnews.com/2024/03/08/in-… $lly